Kristi Jones
Chief Executive Officer chez NEXIMMUNE, INC.
Fortune : 16 398 $ au 31/03/2024
Profil
Kristi Jones is currently the President, Chief Executive Officer & Director at NexImmune, Inc. She previously worked as the Head-Immunology & Ophthalmology at Genentech, Inc. and as the Vice President-Global Strategic Marketing at MedImmune LLC.
Additionally, she held the position of Vice President-Portfolio Strategy at AstraZeneca, Inc. from 2013 to 2015.
Ms. Jones completed her undergraduate degree at Texas Tech University and Ut College of Pharmacy.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
NEXIMMUNE, INC.
0,25% | 31/10/2023 | 2 923 ( 0,25% ) | 16 398 $ | 31/03/2024 |
Postes actifs de Kristi Jones
Sociétés | Poste | Début |
---|---|---|
NEXIMMUNE, INC. | Chief Executive Officer | 15/02/2022 |
Anciens postes connus de Kristi Jones
Sociétés | Poste | Fin |
---|---|---|
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Corporate Officer/Principal | 01/01/2015 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | - |
Formation de Kristi Jones
Texas Tech University | Undergraduate Degree |
Ut College of Pharmacy | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
NEXIMMUNE, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Health Technology |